Last reviewed · How we verify

NCT03381365

Efficacy of an Anorectal Fistula Plug With Sealing of the Internal Opening as a Treatment for Perianal Fistula

Terminated NA Last updated 18 January 2020
What this trial tests

NA trial testing CuraSeal Percutaneous Intraluminal Closure System in Fistula in Ano in 6 participants. Terminated before completion.

Timeline
1 September 2016
Primary endpoint
31 December 2018
31 December 2018

Quick facts

Lead sponsorLondon North West Healthcare NHS Trust
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment6
Start date1 September 2016
Primary completion31 December 2018
Estimated completion31 December 2018
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

London North West Healthcare NHS Trust — full company profile →

Who can join

Adults 18 to 80, any sex, with Fistula in Ano. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to assess the efficacy of the Curaseal anal plug in patients with idiopathic uncomplicated fistulous tracts. Healing of the fistula tract will be assessed both clinically and radiologically with MR imaging.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fistula in Ano

Currently open trials in the same condition.

Other London North West Healthcare NHS Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03381365.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing